Benefits of GLP-1-Based Addiction Treatment If approved for broader use in addiction recovery, GLP-1 drugs may offer several advantages: Non-addictive and non-sedating : Unlike benzodiazepines or opioids, theres no risk of psychological dependence
## Head-to-Head Comparison Table | Feature | Orforglipron | Oral Semaglutide | Tirzepatide (Injectable) | |---------|-------------|-----------------|-------------------------| | **Drug type** | Non-peptide small molecule | Peptide with SNAC enhancer | Peptide (GLP-1/GIP dual agonist) | | **Route** | Oral (daily pill) | Oral (daily tablet) | Subcutaneous injection (weekly) | | **Weight loss** | ~15% (Phase 2/3 data) | ~15.1% (OASIS 1) | 20-22.5% (SURMOUNT-1) | | **Fasting required?** | No | Yes (30+ min empty stomach) | N/A (injection) | | **Food/water restrictions** | None | 4 oz water only
At this time, there's no evidence to suggest patients in their 20s, 30s or 40s should stop taking a GLP-1 drug because of the risk of wet age-related macular degeneration, which is exceedingly rare in anyone under 50, the authors note
Sigma-Aldrich), bafilomycin A1 (BML-CM110-0100
Professional Guidance: The Only Path Forward Heres the big picture: We dont know that microdosing tirzepatide is necessarily dangerous, since theres no good data on it